Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2009, p. 1562-1564, Vol. 47, No. 5
0095-1137/09/$08.00+0 doi:10.1128/JCM.00124-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia,1 Department of Medicine, Monash University, Central and Eastern Clinical School, Alfred Hospital, Melbourne, VIC, Australia,2 Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands,3 MadSpain Servicio de Micologia, Centro Nacional de Microbiologia Instituto de Salud Carlos IIrid, Majadahonda, Madrid, Spain,4 ARUP Laboratories, Salt Lake City, Utah,5 Ontario Ministry of Health, Public Health Laboratories Branch, Toronto, Canada,6 the University of Texas Health Science Center at San Antonio, San Antonio, Texas,7 Canisius Wilhelmina Hospital, Nijmegen, The Netherlands8
Received 21 January 2009/ Returned for modification 13 February 2009/ Accepted 22 February 2009
|
|
|---|
|
|
|---|
Balajee et al. evaluated the CSP typing method for typeability, in vitro stability, intralaboratory reproducibility, and concordance with other typing methods (2). However, the interlaboratory reproducibility of this method has not been tested so far. Given that one of the hallmarks of a good typing method is reproducibility which is independent of the operator, place, and time (5), we examined the reproducibility of CSP typing in diverse laboratory settings with data generated under a wide array of experimental conditions.
To test interlaboratory comparability, a panel of A. fumigatus isolates was selected from outbreak isolates whose CSP genotypes were established in a previous study (1, 2). In brief, A. fumigatus isolates used in this study were obtained from previous cases in invasive aspergillosis outbreaks and represented both clonal and distinct genotypes (as verified by the CSP typing, Afut1, and STRAf methods [1, 2]). Species identification of all A. fumigatus isolates was confirmed by sequence comparison of the β-tubulin region (2).
The panel consisted of 14 A. fumigatus isolates: 5 isolates shared the same CSP type (arbitrarily designated genotype 1), 8 isolates shared another CSP type (genotype 2), and 1 isolate had a unique CSP type (genotype 3). In addition, one isolate of Aspergillus flavus (CDC 14) was included as an outlier. Isolates were randomly coded, subcultured on Sabouraud dextrose agar slants, and then sent to seven international laboratories, which represented research, clinical, and reference facilities. Each laboratory was also provided with the following A. fumigatus-specific primers: 5'-TTGGGTGGCATTGTGCCAA (forward) and 5'-GGAGGAACAGTGCTGTTGGTGA (reverse). These primers amplify a
550- to
700-bp fragment of the AFUA_3G08990 gene (dependent on the number of repeats). The participating laboratories cultured, isolated DNA, and performed PCR, sequencing, and DNA sequence analysis using their own routine methods.
The participating laboratories were requested to do the following: (i) generate CSP sequences from the panel of isolates and align the sequences using the Af293 (A. fumigatus isolate whose genome has been completely sequenced) CSP sequence as a reference (GenBank accession no. XM_749624); (ii) visually identify unique and shared genotypes, (iii) assign arbitrary designations to each distinct CSP genotype represented by one or more isolates in the panel—for example, if isolates 1, 2, and 3 were observed to have related genotypes, they were assigned to genotype X; (iv) submit the arbitrary genotype assignments and all sequences in FASTA format via e-mail to the coordinating laboratory; and (v) send detailed protocols on the methods used to generate the sequences to the coordinating laboratory. Each participating laboratory cultured, isolated DNA, and performed PCR, sequencing, and DNA sequence analysis using methods which were routine in their individual laboratories.
Culture methods included seven different media (both broth and agar based) and two incubation temperatures (30°C and 37°C). For DNA extraction, two laboratories harvested mycelial mats and five harvested mycelia and spores from plates. One laboratory collected only spores for DNA isolation. DNA isolation utilized a variety of methods, including commercially available kits and in-house protocols. Only one laboratory quantitated the isolated genomic DNA and made working dilutions of equal concentrations (10 ng/µl), while the others used the genomic DNA directly in the PCR, regardless of concentration.
PCR cycling was carried out on four models of thermal cyclers from three manufacturers. PCR amplifications were accomplished with either commercially available kits (one laboratory) or in-house PCR mixes (six laboratories), utilizing four different polymerases. All laboratories visualized the PCR products on an agarose gel, either commercial or made in-house. PCR product cleanup was performed either by use of the ExoSap enzyme reaction (one laboratory), use of magnetic beads (one laboratory), or column purification (five laboratories). Five laboratories estimated the concentrations of purified PCR products by comparison to a commercial mass ladder standard on an agarose gel, while two laboratories utilized the NanoDrop UV reader (Thermo Scientific) to quantitate the PCR products. One laboratory used the PCR products regardless of the concentration. Sequencing was performed using either Applied Biosystems BD 3.1 or BD 1.1 Dye Terminator chemistry or DYEnamic ET Dye terminator chemistry (GE Healthcare) on three different models of capillary electrophoretic sequencers. One laboratory utilized a commercial sequencing service. All laboratories sequenced both the forward and reverse strands, and sequence editing was performed using the Sequence Analyzer, Contig Express, MacVector, Sequencher, or BioEdit software package. Sequence alignments were assembled using the BioEdit 7.0.9, ClustalX 1.83, Lasergene 8.0, or Mega 4.0 software program.
Despite the wide spectrum of reagents, equipment, and methods used to obtain the CSP sequences, five laboratories assigned the correct genotype to all isolates, yielding 100% concordance (Table 1), while laboratories 5 and 6 reported a concordance of only 93% and 85%, respectively. Laboratory 5 reported the sequence from isolate CDC 3 as genotype 1, when the correct designation for this isolate was genotype 2. Similarly, laboratory 6 identified the isolate CDC6 as genotype 2, when the correct designation should have been genotype 3. The sequences obtained by these laboratories were of high quality and were identical to those of the genotypes that were incorrectly assigned. All other sequences generated by these laboratories were also of high quality with no base-call errors. Therefore, we speculate that laboratories 5 and 6 may have reported incorrect genotype designations because of possible cross-contamination with another isolate from the Aspergillus panel. Alternatively, this could be also be attributed to an inadvertent exchange of samples that may have occurred at any stage of the process from culturing of the organism to DNA extraction to PCR or sequencing. Six laboratories reported that isolate CDC14 yielded no PCR product; this was expected, since this isolate was A. flavus and should not be amplifiable with the primer set provided. Laboratory 6 reported this isolate as belonging to genotype 1, reiterating the likelihood of contamination problems in this laboratory.
|
View this table: [in a new window] |
TABLE 1. CSP genotypes assigned to the Aspergillus panel, as reported by participating laboratories
|
Recently the STRAf method was demonstrated to have good interlaboratory reproducibility for A. fumigatus subtyping (4). In this study, where five laboratories participated, nonspecific amplification products, bleed-through of the different fluorescent labels, and inexperience of laboratories led to some inconsistencies in results. Here, we present results of another multicenter study for A. fumigatus subtyping that also had superior reproducibility. Such multilaboratory reproducibility studies are essential to ensure that any proposed subtyping method can be reliably employed for epidemiological studies.
Additionally and importantly, all data in this study were shared via the Internet, thus confirming that the CSP typing scheme can be a portable and thereby convenient strategy for interlaboratory data sharing or comparison. Furthermore, the data from such studies can easily be stored in a database and archived, retrieved, and reanalyzed at any time, making this a useful tool for global molecular epidemiological investigations of A. fumigatus. The use of inexpensive or free Web-based software for data analysis makes this an attractive tool for small or cost-conscious laboratories. In summary, this international, multilaboratory study confirms the reproducibility and portability of the CSP typing method.
The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the CDC.
Published ahead of print on 4 March 2009. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»